354 related articles for article (PubMed ID: 17077347)
21. Consent before testing men for prostate cancer--a challenge?
Hirst G
Aust Fam Physician; 2005 Oct; 34(10):888. PubMed ID: 16217582
[No Abstract] [Full Text] [Related]
22. Impact of prostate-specific antigen screening on the natural history of prostate cancer.
Rosen MA
Urology; 1995 Dec; 46(6):757-68. PubMed ID: 7502411
[No Abstract] [Full Text] [Related]
23. Prostate cancer screening--is the controversy resolved?
Norcross WA; Ganiats TG
West J Med; 1995 Jul; 163(1):65-6. PubMed ID: 7545340
[No Abstract] [Full Text] [Related]
24. [Detection of prostate cancer: yes or no?].
Van Cangh PJ
Bull Mem Acad R Med Belg; 2006; 161(3-4):159-69. PubMed ID: 17172224
[No Abstract] [Full Text] [Related]
25. [Prostatic cancer screening].
Brasso K; Iversen P
Ugeskr Laeger; 2002 Jan; 164(2):155-7. PubMed ID: 11831076
[No Abstract] [Full Text] [Related]
26. Controversy in clinical cancer screening--prostate-specific antigen.
McKay DA
West J Med; 1994 Jul; 161(1):58-9. PubMed ID: 7524244
[No Abstract] [Full Text] [Related]
27. Re: Is a screening interval of every 4 years for prostate cancer acceptable?
Roobol MJ; Schröder FH
J Natl Cancer Inst; 2008 Feb; 100(3):222; author reply 223-4. PubMed ID: 18230797
[No Abstract] [Full Text] [Related]
28. Why are a high overdiagnosis probability and a long lead time for prostate cancer screening so important?
Barry MJ; Mulley AJ
J Natl Cancer Inst; 2009 Mar; 101(6):362-3. PubMed ID: 19276451
[No Abstract] [Full Text] [Related]
29. Commentary: how serious is getting a diagnosis of prostate cancer?
Barry MJ
Oncologist; 2008 Mar; 13(3):306-8. PubMed ID: 18378541
[No Abstract] [Full Text] [Related]
30. Weighing the benefits and downsides of prostate-specific antigen screening.
Pignone M
Arch Intern Med; 2009 Sep; 169(17):1554-6. PubMed ID: 19786672
[No Abstract] [Full Text] [Related]
31. Early diagnosis of prostate cancer: the continuing debate on the impact on mortality.
Höltl W; Lunglmayr G
Wien Klin Wochenschr; 2005 Jul; 117(13-14):440-1. PubMed ID: 16091868
[No Abstract] [Full Text] [Related]
32. Is prostate-specific antigen velocity useful in early detection of prostate cancer? A critical appraisal of the evidence.
Etzioni RD; Ankerst DP; Weiss NS; Inoue LY; Thompson IM
J Natl Cancer Inst; 2007 Oct; 99(20):1510-5. PubMed ID: 17925534
[TBL] [Abstract][Full Text] [Related]
33. Re: Detection of life-threatening prostate cancer with prostate-specific antigen velocity during a window of curability.
Etzioni RD; Ankerst DP; Thompson IM
J Natl Cancer Inst; 2007 Mar; 99(6):489-90; author reply 490. PubMed ID: 17374841
[No Abstract] [Full Text] [Related]
34. Re: E. David Crawford, Per-Anders Abrahamsson. PSA-based screening for prostate cancer: how does it compare with other cancer screening tests? Eur Urol 2008;54:262-73.
Kvåle R; Hernes E; Bray F
Eur Urol; 2009 May; 55(5):e88-9; author reply e90-1. PubMed ID: 19062155
[No Abstract] [Full Text] [Related]
35. What is the value of screening for prostate cancer in the US?
Albertsen PC
Nat Clin Pract Oncol; 2005 Nov; 2(11):536-7. PubMed ID: 16270077
[No Abstract] [Full Text] [Related]
36. Application of prostate-specific antigen in prostate cancer.
Liang SL
MLO Med Lab Obs; 2008 Oct; 40(10):54, 56-7. PubMed ID: 18988558
[No Abstract] [Full Text] [Related]
37. Prostate-specific antigen (PSA) and PSA velocity: competitors or collaborators in the prediction of curable and clinically significant prostate cancer.
D'Amico AV
J Clin Oncol; 2008 Feb; 26(6):823-4. PubMed ID: 18281649
[No Abstract] [Full Text] [Related]
38. What to do with an abnormal PSA test.
Loeb S; Catalona WJ
Oncologist; 2008 Mar; 13(3):299-305. PubMed ID: 18378540
[TBL] [Abstract][Full Text] [Related]
39. Rural residence and prostate cancer screening with prostate-specific antigen.
Stamatiou K; Skolarikos A
Rural Remote Health; 2009; 9(2):1227. PubMed ID: 19594290
[TBL] [Abstract][Full Text] [Related]
40. Limitations and use of PSA derivatives in the screening and risk stratification of prostate cancer.
Loeb S; Carter HB
Urol Oncol; 2009; 27(6):583-4. PubMed ID: 19879470
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
